Dr. Sagar Parikh, MD

• Psychiatry

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Mcgill University School Of Medicine

  Medical School

• Effects of somatic treatments on suicidal ideation and completed suicides, 2021-10-17

• Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders, 2022-02-07

• Impact of COVID-19 on electroconvulsive therapy practice across Canadian provinces during the first wave of the pandemic, 2023-05-10

• An evaluation of large group cognitive behaviour therapy with mindfulness (CBTm) classes, 2019-05-03

• Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression Machine Learning to Predict Escitalopram Outcome From Electroencephalography Recordings, 2020-01-03

• Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis, 2022-06-27

• Evaluating the Clinical Feasibility of an Artificial Intelligence-Powered, Web-Based Clinical Decision Support System for the Treatment of Depression in Adults: Longitudinal Feasibility Study, 2021-10-25

• Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response, 2021-08-21

• Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy, 2022-03-25

• Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey, 2023-06-26

• A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study, 2023-09-15

• MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes, 2017-05-22

• Effects ofCYP2C19andCYP2D6gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study, 2022-09-06

• Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report, 2023-09-01